Skip to main content
Venture Intelligence Engine™

NeuralLeaf — analytical workbench

AI-powered analysis across health, funding, success probability, risk, and milestones. Every score is decomposable.

Venture Health Score™
78
+4 wk
Top 14% of pre-seed cohort
Success Probability
68%
Benchmark 22% · +46 vs median
Growth Probability (5x in 18mo)
57%
Benchmark 28% · +29 vs median
Next-Round Funding Probability
74%
Benchmark 35% · +39 vs median
Market
84
+6
18% weight

TAM expanding 14% YoY. Two adjacent verticals validated.

Founder
91
+1
14% weight

Domain expertise + 2 prior exits. Repeat-founder premium applies.

Team
72
+2
12% weight

Missing senior ML hire. Recruit before Series A.

Product
78
+4
18% weight

v0.8 ships next week. Latency under SLO across all regions.

Financials
64
+0
14% weight

Burn elevated by infra costs. Negotiate reserved capacity.

Traction
81
+5
14% weight

WoW growth 9% for 6 weeks. Cohort 4 week-4 retention 52%.

Funding
74
+4
10% weight

Lead investor verbal. 2 follow-ons soft-circled at $250K.

Strengths
  • Repeat-founder advantage
    Marcus shipped 2 prior exits in adjacent verticals.
  • Cohort retention
    Week-4 retention 52% — 2.1× sector median.
  • Capital efficient
    $0.42 ARR per $1 raised — top-decile for stage.
  • AI-defensible IP
    Proprietary disease dataset across 14 crops, 8 regions.
Weaknesses
  • Single acquisition channel
    78% of pipeline from one partner. Diversify by Q3.
  • CFO gap
    No senior finance ops. Fractional CFO recommended pre-raise.
  • Documentation debt
    Engineering runbooks 60% complete. Blocks scale hiring.